Updated July 20, 2026
Why everyone gets this wrong
Search “can single-use medical devices be recycled” and most of what comes back is official guidance from the FDA, CDC, and other regulators saying some version of: single-use devices must not be reused. That answer is correct — and it’s answering a different question. Those rules are about putting a device back into a patient. They are not about what happens to a device’s materials after its clinical life is over.
The result: clinical and administrative staff read “must not be reused,” conclude the entire topic is radioactive, and keep paying to landfill devices with real recoverable value. The distinction below is the one to internalize (and to hand your compliance officer).
Reprocessing: regulated, clinical, someone else’s business
Reprocessing means cleaning, remanufacturing, and sterilizing a used single-use device so it can be used on another patient. In the US this is a legitimate, FDA-regulated industry: reprocessors register with the FDA, validate their methods, and take on manufacturer-level responsibility for the devices they return to clinical use. It’s also big business — industry analyses estimate US hospitals could save $2.28 billion through reprocessed devices, and reprocessing programs saved US healthcare roughly $495 million in 2025 (industry-reported figures from AMDR).
The key point for a surgery center: reprocessing is a clinical supply decision with a regulatory apparatus around it. If a vendor is putting devices back into patient care, they need FDA clearance to do it.
Recycling for value: a one-way trip
Device buyback — what ASC Sustain does — is a different transaction entirely. We pay your facility for used devices, collect them in dedicated containers, and route them to materials recovery and non-clinical uses (precious-metal refining from catheter electrodes, research and development, training). The device never returns to patient care. It’s a one-way trip out of your facility.
That’s why the FDA reuse rules aren’t the blocker people assume: nothing is being reused on a patient. The device stops being a medical device and becomes recovered material with a market price — the same way a facility might sell scrap metal, except these particular “scraps” contain platinum-group metals and trade at $5–$65 per device.
The two-column version for your compliance officer
| Question | Reprocessing | Buyback recycling |
|---|---|---|
| Does the device return to patient use? | Yes — that’s the point | Never |
| FDA-regulated activity? | Yes — reprocessor holds clearance | Not a reuse activity; standard shipping & handling rules apply |
| Who pays whom? | You buy reprocessed devices at a discount | The recycler pays you per device |
| Staff workflow | Segregate per reprocessor protocol | Drop device in collection container — seconds per case |
Can you do both?
Yes — they aren’t competitors, they’re different exits for different devices. Some facilities run a reprocessing program for eligible device types and a buyback program for devices reprocessors don’t take (or that have more value as recovered material). The mistake is doing neither and paying a hauler to landfill everything.
The one-sentence summary: reprocessing puts devices back into patients under FDA oversight; recycling buyback pays you for devices that permanently exit clinical use. ASC Sustain is the second one — we never reprocess, and nothing we collect is ever reused.
What to do with this
- Share this page (or the table above) with your compliance officer — the reuse/recycle distinction usually settles the conversation.
- Run the calculator to see what your discarded devices trade for at published market rates.
- See how the program works — free kits, no sorting, itemized payment.
Sources
- FDA — Reprocessing of Single-Use Devices (regulatory overview)
- AMDR — Association of Medical Device Reprocessors, industry reports ($2.28B savings analysis; industry-reported)
- Practice Greenhealth — Reprocessed medical devices topic page & 2024 benchmark data
- BMJ Open — Carbon footprints of single-use vs reusable medical devices (systematic review of 61 LCAs)